Venlafaxine-induced serotonin syndrome with relapse following amitriptyline

Postgraduate Medical Journal

Volumn 76, Issue 894, 2000, Pages 254-256

  Perry, Nicholas K ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adverse drug reaction; Amitriptyline; Serotonin syndrome; Venlafaxine

Indexed keywords

AMITRIPTYLINE; BECLOMETASONE DIPROPIONATE; OXITROPIUM BROMIDE; SERTRALINE; VENLAFAXINE;

AGED; ARTICLE; ASTHMA; CACHEXIA; CASE REPORT; CONFUSION; DEPRESSION; DRUG INDUCED DISEASE; ELECTROENCEPHALOGRAPHY; HUMAN; HYPOTENSION; MALE; SEROTONIN SYNDROME;

ADRENERGIC UPTAKE INHIBITORS; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; RECURRENCE; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 0034103871     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.76.894.254     Document Type: Article

References (6)

1. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
2. Bodner RA, Lynch T, Lewis L, et al. Serotonin syndrome. Neurology 1995;45:219-23.
3. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997;17:208-21.
4. Lejoyeux M, Finejre F, Adis J. The serotonin syndrome. Am J Psychiatry 1992;149:1410-1.
5. Dike G. Triphasic waves in serotonin syndrome (letter). J Neurol Neurosurg Psychiatry 1997;62:200.
6. Meynaar IA, Peelers AJ, Mulder AH, et al. Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine. Neth J Med 1997;50:243-5.